Turning Trash into Treasure

In theory, using cellulosic biomass makes a lot of sense. Take what would otherwise be waste or animal feed--agricultural and forestry residues, recycled paper, and other organic waste--treat them with acid and the right enzymes, and create relatively clean-burning ethanol and other byproducts. In doing so, there would be less landfill, pollution, and a reduced national dependence on oil, more than 55 percent of which comes from overseas. In reality, while the apparent energy crisis has made so

Written byEugene Russo
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

In reality, while the apparent energy crisis has made so-called cellulosic biomass technologies more attractive, the industry, like that of other renewable fuels, including wind and solar power, continues to face scientific, political, and economic hurdles--as it has for years. "We're still treated as a marginal industry," says Katherine Hamilton, co-director of the industry advocacy group the American Bioenergy Association, referring to all renewables. "We're not at the table with coal and oil and gas and nukes. We're a way to make [legislators] look good, but not really do anything."

As with researchers and advocates in other renewable fuels areas, those involved in cellulosic biomass have gotten mixed signals from the federal government, whose research and processing-plant startup funds are crucial if cellulose-derived ethanol is to replace gasoline to any significant degree. The Department of Energy (DOE) and companies engaged in cellulosic biomass research hope that scientific advances will soon ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies